Advisory Research’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
GCGM
Advisory Research's TDOC Position: Q2 2021 in Review
Advisory Research sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 4,738 shares — an estimated $861K sold.
Advisory Research first reported a position in TDOC in Q1 2017 and held it in 17 quarters. The position peaked at $6.27M in Q3 2018. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.
- Advisory Research reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
- Advisory Research sold 4,738 Teladoc Health shares in Q2 2021, an estimated $861K.
- Advisory Research first reported a position in Teladoc Health in Q1 2017 and held it in 17 quarters.
- Advisory Research's Teladoc Health position peaked at $6.27M in Q3 2018.
- 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.
Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.